The miR-146a expression in PBMC and serum TGF-b and IL-1b levels may act as blood markers in NSCLC patients.miR-146a has a major effect on programmed cell death, and its overexpression suppresses cell migration and proliferation in NSCLC cell lines. The gene discussed is IL1B; the disease is non-small cell lung carcinoma.